Fig. 3From: Hyaluronic acid and platelet-rich plasma, a new therapeutic alternative for scleroderma patients: a prospective open-label studyGraphs of clinical parameters (maximum mouth’s opening, distance between upper and lower incisors, inter-commissural distance, upper and lower lip’s thickness) in all patients (each line represents a different patients) for each time point (baseline (T0), during the third injection (T1), the 1-month follow-up (T2), the 3-month follow-up (T3), and the 24-month follow-up (T4))Back to article page